ScoreWhy is BioArctic AB ?
1
Negative results in Mar 26
- NET PROFIT(HY) At SEK 203.56 MM has Grown at -79.44%
- PRE-TAX PROFIT(Q) At SEK 224.12 MM has Fallen at -28.6%
- NET SALES(Q) At SEK 437.58 MM has Fallen at -12.44%
2
With ROE of 51.97%, it has a fair valuation with a 14.36 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 76.12%, its profits have risen by 677.3% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is BioArctic AB for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
BioArctic AB
76.12%
0.69
49.39%
OMX Stockholm 30
30.13%
1.89
15.95%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
100.08%
EBIT Growth (5y)
78.36%
EBIT to Interest (avg)
-8.97
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.58
Tax Ratio
3.43%
Dividend Payout Ratio
17.32%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
17.86%
ROE (avg)
15.35%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
14.36
EV to EBIT
19.05
EV to EBITDA
18.96
EV to Capital Employed
-125.55
EV to Sales
13.04
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
51.97%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK 1,253.27 MM
CASH AND EQV(HY)
Highest at SEK 4,225.07 MM
-19What is not working for the Company
NET PROFIT(HY)
At SEK 203.56 MM has Grown at -79.44%
PRE-TAX PROFIT(Q)
At SEK 224.12 MM has Fallen at -28.6%
NET SALES(Q)
At SEK 437.58 MM has Fallen at -12.44%
Here's what is working for BioArctic AB
Operating Cash Flow
Highest at SEK 1,253.27 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Cash and Eqv
Highest at SEK 4,225.07 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for BioArctic AB
Net Profit
At SEK 203.56 MM has Grown at -79.44%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Pre-Tax Profit
At SEK 224.12 MM has Fallen at -28.6%
over average net sales of the previous four periods of SEK 313.9 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Net Sales
At SEK 437.58 MM has Fallen at -12.44%
over average net sales of the previous four periods of SEK 499.78 MMMOJO Watch
Near term sales trend is negative
Net Sales (SEK MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
